Profile data is unavailable for this security.
About the company
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
- Revenue in JPY (TTM)578.03bn
- Net income in JPY10.24bn
- Incorporated1948
- Employees38.77k
- LocationNipro Corp3-26, Senrioka shin-machiSETTSU-SHI 566-8510JapanJPN
- Phone+81 663722331
- Fax+81 663717422
- Websitehttps://www.nipro.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Menicon Co Ltd | 115.13bn | 5.10bn | 114.45bn | 4.06k | 24.12 | 1.42 | 8.88 | 0.9941 | 61.92 | 61.92 | 1,393.25 | 1,052.59 | 0.71 | 3.12 | 8.48 | 28,385,600.00 | 3.14 | 5.12 | 3.65 | 6.41 | 52.06 | 53.07 | 4.43 | 5.94 | 3.08 | 17.19 | 0.4695 | 24.72 | 10.00 | 7.52 | 13.83 | 22.66 | 21.95 | 14.87 |
| PHC Holdings Corp | 348.01bn | -17.78bn | 146.82bn | 9.40k | -- | 1.17 | 15.63 | 0.4219 | -141.63 | -141.63 | 2,768.00 | 989.95 | 0.6266 | 3.48 | 5.27 | 37,010,950.00 | -3.21 | -- | -4.22 | -- | 45.43 | -- | -5.12 | -- | 0.8877 | -0.4117 | 0.6975 | -- | 4.69 | -- | 61.91 | -- | -- | -- |
| Paramount Bed Holdings Co Ltd | 100.96bn | 9.14bn | 163.40bn | 3.95k | 16.87 | 1.16 | 8.73 | 1.62 | 156.82 | 156.82 | 1,731.85 | 2,284.02 | 0.5968 | 4.38 | 4.48 | 25,584,390.00 | 5.40 | 5.33 | 6.19 | 6.30 | 48.00 | 46.44 | 9.06 | 9.26 | 3.82 | -- | 0.0409 | 38.33 | 9.58 | 5.10 | 1.35 | 1.95 | 11.41 | 5.57 |
| Mani Inc | 26.37bn | 6.58bn | 198.63bn | 3.69k | 27.79 | 3.54 | 22.93 | 7.53 | 66.82 | 66.82 | 267.74 | 523.80 | 0.4933 | 1.52 | 12.00 | 7,156,310.00 | 12.31 | 11.44 | 13.21 | 12.31 | 64.22 | 63.28 | 24.96 | 26.11 | 7.32 | -- | 0.001 | 51.25 | 19.95 | 4.03 | 12.53 | 9.56 | 24.12 | 20.11 |
| Nipro Corp | 578.03bn | 10.24bn | 216.64bn | 38.77k | 23.41 | 0.8467 | 3.22 | 0.3748 | 53.97 | 53.97 | 3,232.30 | 1,492.32 | 0.5349 | 1.86 | 3.33 | 14,909,290.00 | 1.05 | 0.8275 | 1.61 | 1.26 | 30.03 | 30.30 | 1.97 | 1.54 | 0.8539 | -- | 0.6895 | 60.43 | 10.19 | 6.64 | -66.01 | -17.31 | 6.34 | -5.05 |
| NAKANISHI INC. | 59.69bn | 22.84bn | 226.45bn | 2.05k | 9.06 | 1.83 | 8.60 | 3.79 | 267.42 | 267.42 | 698.69 | 1,327.05 | 0.4906 | 1.16 | 8.43 | 29,132,440.00 | 18.77 | 12.71 | 21.55 | 14.02 | 60.52 | 61.41 | 38.26 | 26.60 | 2.05 | -- | 0.0934 | 28.12 | 22.64 | 10.31 | 83.10 | 24.65 | 11.28 | 12.30 |
| Ship Healthcare Holdings Inc | 618.22bn | 11.84bn | 239.02bn | 8.05k | 20.04 | 1.67 | 12.34 | 0.3866 | 117.30 | 117.30 | 6,087.68 | 1,408.21 | 1.67 | 17.65 | 5.23 | 76,835,940.00 | 3.15 | 3.68 | 6.58 | 6.84 | 10.38 | 10.55 | 1.88 | 2.36 | 1.18 | -- | 0.2888 | 31.05 | 11.26 | 6.10 | -0.8955 | 3.11 | -7.86 | 5.59 |
| Fukuda Denshi Co Ltd | 140.43bn | 19.31bn | 252.15bn | 3.38k | 10.47 | 1.17 | 8.74 | 1.80 | 638.29 | 638.29 | 4,642.15 | 5,726.01 | 0.6919 | 3.30 | 4.08 | 41,521,290.00 | 9.51 | 7.50 | 11.26 | 9.60 | 53.61 | 45.27 | 13.75 | 9.96 | 3.31 | -- | 0.0103 | 28.85 | 1.93 | 0.879 | 6.55 | 13.14 | 10.88 | 14.87 |
Data as of May 02 2024. Currency figures normalised to Nipro Corp's reporting currency: Japanese Yen JPY
16.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 15 Apr 2024 | 5.20m | 3.04% |
| T. Rowe Price International Ltd.as of 31 Mar 2024 | 4.41m | 2.57% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 3.95m | 2.31% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 2.89m | 1.69% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 2.39m | 1.39% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 2.34m | 1.36% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.07m | 1.21% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 1.66m | 0.97% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 1.61m | 0.94% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 985.80k | 0.58% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
